Role of thoracic radiotherapy in small cell lung cancer

Tobias, J S
June 1993
Thorax;Jun1993, Vol. 48 Issue 6, p587
Academic Journal
No abstract available.


Related Articles

  • Palliative thoracic radiotherapy dose, non-small cell lung cancer with oligometastases and prognosis. Ampil, Federico L.; Caldito, Gloria // Annals of Thoracic Medicine;Jul-Sep2011, Vol. 6 Issue 3, p154 

    A letter to the editor is presented in response to the article on palliative thoracic radiotherapy (PTR) dose and prognosis on non-small cell lung cancer (NSCLC) with oligometastases.

  • Thoracic Radiotherapy Does Not Prolong Survival in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer. Johnson, David H.; Einhorn, Lawrence H.; Bartolucci, Alfred; Birch, Robert; Omura, George; Perez, Carlos A.; Greco, F. Anthony // Annals of Internal Medicine;7/1/90, Vol. 113 Issue 1, p33 

    Compares the survival of patients with locally advanced non-small cell lung cancer treated with single-agent vindesine, thoracic radiotherapy, or both treatment modalities. Characteristics of the patients; Response to induction therapy; Adequacy of radiotherapy.

  • Combined Modality Treatment of Limited Stage Small Cell Carcinoma of the Lung. Yee, Don; Danielson, Brita; Roa, Wilson // Reviews on Recent Clinical Trials;May2008, Vol. 3 Issue 2, p150 

    Small cell lung carcinoma comprises approximately 10-20% of all lung cancers. At the time of diagnosis, 20-30% of patients have what is considered limited stage disease. Historically, chemotherapy has been the mainstay of treatment for small cell lung cancer, but more recent evidence from large...

  • Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer. Yamada, M.; Kudoh, S.; Fukuda, H.; Nakagawa, K.; Yamamoto, N.; Nishimura, Y.; Negoro, S.; Takeda, K.; Tanaka, M.; Fukuoka, M. // British Journal of Cancer;7/29/2002, Vol. 87 Issue 3, p258 

    Dose-escalation study was performed to evaluate the maximum tolerated dose, recommended dose and toxicity profile of weekly irinotecan with daily carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer. Thirty-one previously untreated...

  • Bevacizumab.  // Reactions Weekly;6/2/2012, Issue 1404, p10 

    The article describes several cases of pneumonitis in patients with stage III non-small cell lung cancer while taking increasing doses of bevacizumab and concurrent thoracic radiotherapy.

  • Chemotherapy and Radiotherapy.  // Current Medical Literature: Lung Cancer;2007, Vol. 1 Issue 2, p44 

    The article presents several studies on chemotherapy and radiotherapy. A study by E. H. Huang, Z. Liao and J. D. Cox et al published in a 2007 issue of the "International Journal of Radiation of Oncology, Biology and Physics" focused on the treatment of non-small-cell lung cancer with induction...

  • Chemotherapy and Radiotherapy.  // Current Medical Literature: Lung Cancer;2011, Vol. 4 Issue 3, p81 

    The article discusses various studies on lung cancer chemotherapy and radiotherapy. It includes the study that focused on the overall survival of patients with non-squamous non-small cell lung cancer with cisplatin-gemcitabine and bevacizumab as first line therapy. Another study compared second...

  • Chemotherapy and Radiotherapy.  // Current Medical Literature: Lung Cancer;2012, Vol. 6 Issue 1, p19 

    The article offers information on various studies related to chemotherapy and radiotherapy. One study examined adjuvant chemotherapy for non-small-cell lung cancer in the elderly population in Ontario. Another study investigated the superiority of induction chemoradiation to induction...

  • Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. Sourami, R.L.; Geddes, D.M.; Spiro, S.G.; Harper, P.G.; Tobias, J.S.; Mantell, B.S.; Fearon, F.; Bradbury, I. // British Medical Journal (Clinical Research Edition);6/2/1984, Vol. 288 Issue 6431, p1643 

    Examines cell cancer of the lung treated with combination of radiotherapy and chemotherapy. Categorization of the responses of the patient treated; Effects of the radiotherapy according to the disease and quality of chemotherapy; Significance of the thoracic radiotherapy on patients survival.

  • Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer. Halmos, Balazs // Current Medical Literature: Lung Cancer;2013, Vol. 7 Issue 1, p13 

    The author comments on the study "Phase III Trial of Concurrent Thoracic Radiotherapy With Either First- or Third-Cycle Chemotherapy for Limited-Disease Small-Cell Lung Cancer," by J. M. Sun et al published in a 2013 issue of the "Annals of Oncology." The author finds that the study indicated...


Read the Article


Sign out of this library

Other Topics